UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Frequent Downregulation of miR-34 Family in Human Ovarian Cancers

Clinical cancer research, 2010-02, Vol.16 (4), p.1119-1128

2010

Volltextzugriff (PDF)

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

The New England journal of medicine, 2008-12, Vol.359 (25), p.2641-2650

2008

Volltextzugriff (PDF)

Stress Hormone–Mediated Invasion of Ovarian Cancer Cells

Clinical cancer research, 2006-01, Vol.12 (2), p.369-375

2006

Volltextzugriff (PDF)

The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine

International journal of molecular sciences, 2022-09, Vol.23 (17), p.9981

2022

Volltextzugriff (PDF)

Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Clinical cancer research, 2021-08, Vol.27 (15), p.4455-4455

2021

Volltextzugriff (PDF)

Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (22), p.10976-10983

2007

Volltextzugriff (PDF)

Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

The lancet oncology, 2011-11, Vol.12 (12), p.1109-1117

2011

Volltextzugriff (PDF)

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (4), p.1757-1768

2007

Volltextzugriff (PDF)

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Clinical cancer research, 2006-08, Vol.12 (16), p.4916-4924

2006

Volltextzugriff (PDF)

Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer

Clinical cancer research, 2007-12, Vol.13 (24), p.7487-7495

2007

Volltextzugriff (PDF)

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker

Cancer, 2010-04, Vol.116 (8), p.1918-1925

2010

Volltextzugriff (PDF)

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

JNCI : Journal of the National Cancer Institute, 2008-03, Vol.100 (5), p.359-372

2008

Volltextzugriff (PDF)

Focal adhesion kinasetargeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy

Clinical cancer research, 2006-08, Vol.12 (16), p.4916-4924

2006

Volltextzugriff (PDF)

The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Clinical cancer research, 2006-03, Vol.12 (6), p.1707-1714

2006

Volltextzugriff (PDF)

Functional significance of VEGFR‐2 on ovarian cancer cells

International journal of cancer, 2009-03, Vol.124 (5), p.1045-1053

2009

Volltextzugriff (PDF)

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

Clinical cancer research, 2008-06, Vol.14 (11), p.3372-3379

2008

Volltextzugriff (PDF)

Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia

Blood, 2013-05, Vol.121 (22), p.e138-e148

2013

Volltextzugriff (PDF)

Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10389-10396

2007

Volltextzugriff (PDF)

Relaxin Promotes Prostate Cancer Progression

Clinical cancer research, 2007-03, Vol.13 (6), p.1695-1702

2007

Volltextzugriff (PDF)

Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Nature medicine, 2021-12, Vol.27 (12), p.2246-2246

2021

Volltextzugriff (PDF)

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

Cancer research (Chicago, Ill.), 2007, Vol.67 (1), p.281-288

2007

Volltextzugriff (PDF)

Genetic Targeting of Relaxin and Insulin-Like Factor 3 Receptors in Mice

Endocrinology (Philadelphia), 2004-10, Vol.145 (10), p.4712-4720

2004

Volltextzugriff (PDF)

Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma

Clinical cancer research, 2012-06, Vol.18 (11), p.3197-3206

2012

Volltextzugriff (PDF)

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Clinical cancer research, 2019-05, Vol.25 (10), p.3194-3194

2019

Volltextzugriff (PDF)

Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway

Clinical cancer research, 2007-06, Vol.13 (11), p.3423-3430

2007

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Frequent Downregulation of miR-34 Family in Human Ovarian Cancers

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

Stress Hormone–Mediated Invasion of Ovarian Cancer Cells

The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine

Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma

Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

Focal adhesion kinasetargeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy

The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Functional significance of VEGFR‐2 on ovarian cancer cells

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia

Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer

Relaxin Promotes Prostate Cancer Progression

Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

Genetic Targeting of Relaxin and Insulin-Like Factor 3 Receptors in Mice

Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway

Suchergebnisse filtern